Publication dates

Pancreatic Cancer Industry, March 2015 Market Reports from Top Publishers

You might be interested in: cancer, therapeutics, melanoma, medical equipment, cancer drug, drug, oncology, breast cancer, colorectal cancer, leukemia, lymphoma, prostate cancer.


 
1-10 of about 100 reports for Pancreatic Cancer

Therapeutics for ”Silent” Cancers

Therapeutics for ”Silent” Cancers

  • $ 6 650
  • Industry report
  • February 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual ...

Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Pathology in United States: Metastatic Pancreatic Cancer – Pipeline Review, H1 2012

Pathology in United States: Metastatic Pancreatic Cancer – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

This report provides information on the therapeutic development for Metastatic Pancreatic Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

Pancreatic Cancer Drug Pathway Analyzer 2015

Pancreatic Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 325 targeted molecular therapies known to affect more than 252 specific intracellular signaling pathways ...

AB Science (Symbol:AB) SWOT Analysis, Strategy, Revenues and Profits

AB Science (Symbol:AB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Acuvax Ltd (Symbol:ACU) SWOT Analysis, Strategy, Revenues and Profits

Acuvax Ltd (Symbol:ACU) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Aposense Ltd. (Symbol:APOS) SWOT Analysis, Strategy, Revenues and Profits

Aposense Ltd. (Symbol:APOS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

IsoRay, Inc. (Symbol:ISR) SWOT Analysis, Strategy, Revenues and Profits

IsoRay, Inc. (Symbol:ISR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

About 800 reports for Pancreatic Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2013
    64 pages
  • Cancer  

  • United States  

    North America  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.